San Diego-based rBIO moved to Houston to take advantage of the growing ecosystem of biomanufacturing and synthetic biology. Photo via Getty Images Cameron Owen had an idea for a synthetic biology application, and he pitched it to a handful of postdoctoral programs. When he received the feedback that he didn’t

For many Type-1 diabetes patients and the health plans that cover them, the cost of insulin is a burdensome problem. And amidst a global supply chain crisis, access to insulin has only compounded the issue.   San Diego-based rBIO looks to solve both problems with a novel approach to manufacturing the drug.

Scaling insulin production with Cameron Owen, CEO/co-Founder of rBio It’s not hard to find someone who has been affected by diabetes and the rising cost of insulin. In fact, today’s guest says that 1 in 10 people in the US today have diabetes and that figure is expected to rise